Context Deep brain stimulation (DBS) may be an effective intervention for treatment-resistant
depression (TRD), but available data are limited. Objective To assess the efficacy and …

Background Subcallosal cingulate white matter (SCC) deep brain stimulation (DBS) is an
evolving investigational treatment for depression. Mechanisms of action are hypothesized to …

Target identification and contact selection are known contributors to variability in efficacy
across different clinical indications of deep brain stimulation surgery. A retrospective analysis of …

Deep brain stimulation (DBS) of the subcallosal cingulate (SCC) can provide long-term symptom
relief for treatment-resistant depression (TRD) 1 . However, achieving stable recovery is …

… response in SCC DBS for TRD, Riva Posse and colleagues performed a retrospective analysis
on … Given these retrospective results, Riva-Posse et al. sought to test the utility of using an …

Objective: Deep brain stimulation of the subcallosal cingulate (SCC DBS) has been studied
as a potential treatment for severe and refractory major depressive disorder since 2005. The …

Importance The clinical utility of monitoring behavioral changes during intraoperative testing
of subcallosal cingulate deep brain stimulation is unknown. Objective To characterize the …

Objective Create a software tool to facilitate tractography-based deep brain stimulation (DBS)
electrode targeting within the patient-specific stereotactic coordinate system used in the …

Objective Refractory psychiatric disease is a major cause of morbidity and mortality worldwide,
and there is a great need for new treatments. In the last decade, investigators piloted …

BackgroundPrior trials suggest that intravenous racemic ketamine is a highly effective for
treatment-resistant depression (TRD), but phase 3 trials of racemic ketamine are needed.…